. 2020 Feb 13;7(7):1903354. doi: 10.1002/advs.201903354

Table 1.

Results of thalassemia related mutations in candidate fetal trophoblastic cells

Patient	Age	Gestational age (week)	Single cells	Genotypes for	Father	Mother	Fetus (rare‐cell analysis)	AC/CVS/ postnatal testing
P1	29	22⁺¹	5	α‐globin	–^SEA/ α α	–^SEA/ α α	–^SEA/ α α	–^SEA/ α α
P2	25	23⁺⁶	6	β‐globin	normal	CDs41/42(‐TCTT)	normal	normal
P4	31	4⁺⁴	6	α‐globin	–^SEA/ α α	α α/ α α	–^SEA/ α α	–^SEA/ α α
P5	30	29⁺²	5	α‐globin	–^SEA/ α α	–^SEA/ α α	–^SEA/ –^SEA	–^SEA/ –^SEA
P18	19	13⁺⁶	5	α‐globin	α α/ α α	–^SEA/ α α	α α/ α α	normal
P30	25	32⁺⁶	4	α‐globin	–^SEA/ α α	–^SEA/ α α	–^SEA/ –^SEA	–^SEA/ –^SEA
P50	17	10	4	β‐globin	normal	CDs41/42(‐TCTT)	CDs41/42(‐TCTT)	CDs41/42(‐TCTT)
P54	27	17⁺⁵	5	β‐globin	IVS‐II‐654(C > T)	IVS‐II‐654(C > T)	normal	normal
P58	27	17⁺²	4	β‐globin	IVS‐II‐654(C > T)	−28(A > G)	−28(A > G)	−28(A > G)
P59	29	32	4	β‐globin	normal	IVS‐II‐654(C > T)	normal	normal
P60	27	16	7	α‐and β‐globin	–^SEA/ α α, −28(A > G)	normal	−28(A > G)	−28(A > G)